Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats

Mi Ra Noh, Sung Koo Kim, Woong Sun, Soon Kwon Park, Hyung Chol Choi, Ji Hyae Lim, Il Hwan Kim, Hyun Ju Kim, Hyun Kim, Baik Lin Eun

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Perinatal hypoxia-ischemia is one of the most common risk factors for neonatal mortality and permanent neurodevelopmental disability. Topiramate [2,3:4,5-bis-o-(1-methylethylidene) β-d-fructo-pyranose sulfamate; TPM] is widely used as an antiepileptic agent with multiple targets. In the present study, we found that treatment with TPM reduced the neuronal damage induced by oxygen-glucose deprivation in vitro with strong inhibition of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor. Because perinatal hypoxia is mediated, at least in part, by aberrant glutamatergic excitation, we tested whether treatment with TPM was effective against perinatal brain hypoxia-ischemia. Intraperitoneal or oral pretreatment with TPM was found to reduce the brain damage and subsequent cognitive impairments induced by transient hypoxia-ischemia in perinatal rats. A potent neuroprotective effect of TPM was also observed in a post-treatment regime although post-treatment window appears to be relatively narrow (<2 h). These results suggest that TPM treatment may be beneficial for perinatal hypoxia-ischemia and related damage.

Original languageEnglish (US)
Pages (from-to)470-478
Number of pages9
JournalExperimental Neurology
Volume201
Issue number2
DOIs
StatePublished - Oct 1 2006

Fingerprint

Neuroprotective Agents
Brain Injuries
Ischemia
Brain Hypoxia-Ischemia
AMPA Receptors
Infant Mortality
Anticonvulsants
Oxygen
Glucose
topiramate
Hypoxia
Brain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Developmental Neuroscience

Cite this

Noh, M. R., Kim, S. K., Sun, W., Park, S. K., Choi, H. C., Lim, J. H., ... Eun, B. L. (2006). Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Experimental Neurology, 201(2), 470-478. https://doi.org/10.1016/j.expneurol.2006.04.038

Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. / Noh, Mi Ra; Kim, Sung Koo; Sun, Woong; Park, Soon Kwon; Choi, Hyung Chol; Lim, Ji Hyae; Kim, Il Hwan; Kim, Hyun Ju; Kim, Hyun; Eun, Baik Lin.

In: Experimental Neurology, Vol. 201, No. 2, 01.10.2006, p. 470-478.

Research output: Contribution to journalArticle

Noh, MR, Kim, SK, Sun, W, Park, SK, Choi, HC, Lim, JH, Kim, IH, Kim, HJ, Kim, H & Eun, BL 2006, 'Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats', Experimental Neurology, vol. 201, no. 2, pp. 470-478. https://doi.org/10.1016/j.expneurol.2006.04.038
Noh, Mi Ra ; Kim, Sung Koo ; Sun, Woong ; Park, Soon Kwon ; Choi, Hyung Chol ; Lim, Ji Hyae ; Kim, Il Hwan ; Kim, Hyun Ju ; Kim, Hyun ; Eun, Baik Lin. / Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. In: Experimental Neurology. 2006 ; Vol. 201, No. 2. pp. 470-478.
@article{adaa1a051c964b9bb356cf9eaa4351a6,
title = "Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats",
abstract = "Perinatal hypoxia-ischemia is one of the most common risk factors for neonatal mortality and permanent neurodevelopmental disability. Topiramate [2,3:4,5-bis-o-(1-methylethylidene) β-d-fructo-pyranose sulfamate; TPM] is widely used as an antiepileptic agent with multiple targets. In the present study, we found that treatment with TPM reduced the neuronal damage induced by oxygen-glucose deprivation in vitro with strong inhibition of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor. Because perinatal hypoxia is mediated, at least in part, by aberrant glutamatergic excitation, we tested whether treatment with TPM was effective against perinatal brain hypoxia-ischemia. Intraperitoneal or oral pretreatment with TPM was found to reduce the brain damage and subsequent cognitive impairments induced by transient hypoxia-ischemia in perinatal rats. A potent neuroprotective effect of TPM was also observed in a post-treatment regime although post-treatment window appears to be relatively narrow (<2 h). These results suggest that TPM treatment may be beneficial for perinatal hypoxia-ischemia and related damage.",
author = "Noh, {Mi Ra} and Kim, {Sung Koo} and Woong Sun and Park, {Soon Kwon} and Choi, {Hyung Chol} and Lim, {Ji Hyae} and Kim, {Il Hwan} and Kim, {Hyun Ju} and Hyun Kim and Eun, {Baik Lin}",
year = "2006",
month = "10",
day = "1",
doi = "10.1016/j.expneurol.2006.04.038",
language = "English (US)",
volume = "201",
pages = "470--478",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats

AU - Noh, Mi Ra

AU - Kim, Sung Koo

AU - Sun, Woong

AU - Park, Soon Kwon

AU - Choi, Hyung Chol

AU - Lim, Ji Hyae

AU - Kim, Il Hwan

AU - Kim, Hyun Ju

AU - Kim, Hyun

AU - Eun, Baik Lin

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Perinatal hypoxia-ischemia is one of the most common risk factors for neonatal mortality and permanent neurodevelopmental disability. Topiramate [2,3:4,5-bis-o-(1-methylethylidene) β-d-fructo-pyranose sulfamate; TPM] is widely used as an antiepileptic agent with multiple targets. In the present study, we found that treatment with TPM reduced the neuronal damage induced by oxygen-glucose deprivation in vitro with strong inhibition of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor. Because perinatal hypoxia is mediated, at least in part, by aberrant glutamatergic excitation, we tested whether treatment with TPM was effective against perinatal brain hypoxia-ischemia. Intraperitoneal or oral pretreatment with TPM was found to reduce the brain damage and subsequent cognitive impairments induced by transient hypoxia-ischemia in perinatal rats. A potent neuroprotective effect of TPM was also observed in a post-treatment regime although post-treatment window appears to be relatively narrow (<2 h). These results suggest that TPM treatment may be beneficial for perinatal hypoxia-ischemia and related damage.

AB - Perinatal hypoxia-ischemia is one of the most common risk factors for neonatal mortality and permanent neurodevelopmental disability. Topiramate [2,3:4,5-bis-o-(1-methylethylidene) β-d-fructo-pyranose sulfamate; TPM] is widely used as an antiepileptic agent with multiple targets. In the present study, we found that treatment with TPM reduced the neuronal damage induced by oxygen-glucose deprivation in vitro with strong inhibition of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor. Because perinatal hypoxia is mediated, at least in part, by aberrant glutamatergic excitation, we tested whether treatment with TPM was effective against perinatal brain hypoxia-ischemia. Intraperitoneal or oral pretreatment with TPM was found to reduce the brain damage and subsequent cognitive impairments induced by transient hypoxia-ischemia in perinatal rats. A potent neuroprotective effect of TPM was also observed in a post-treatment regime although post-treatment window appears to be relatively narrow (<2 h). These results suggest that TPM treatment may be beneficial for perinatal hypoxia-ischemia and related damage.

UR - http://www.scopus.com/inward/record.url?scp=33748413906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748413906&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2006.04.038

DO - 10.1016/j.expneurol.2006.04.038

M3 - Article

VL - 201

SP - 470

EP - 478

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -